Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at …

Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for ...

Scientists stunned by what a single dose of magic mushrooms does to the brain one month later

Tracking microstructural shifts in nerve tracts The research team identified these anatomical modifications using diffusion ...

Alzheon, Inc.: Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer's Patients ...

Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Gadget Review on MSN

Brain scans reveal why ME/CFS causes brain fog

ME/CFS brain fog is measurable on an MRI - new research links impaired glymphatic waste clearance to sleep disruption and ...